Background The α-thalassaemias are the commonest genetic disorders of humans. It is generally believed that this high frequency reflects selection through a survival advantage against death from malaria; nevertheless, the epidemiological description of the relationships between α-thalassaemia, malaria, and other common causes of child mortality remains incomplete. Methods and Findings We studied the α+-thalassaemia-specific incidence of malaria and other common childhood diseases in two cohorts of children living on the coast of Kenya. We found no associations between α+-thalassaemia and the prevalence of symptomless Plasmodium falciparum parasitaemia, the incidence of uncomplicated P. falciparum disease, or parasite densities during mild or severe malaria episodes. However, we found significant negative associations between α+-thalassaemia and the incidence rates of severe malaria and severe anaemia (haemoglobin concentration < 50 g/l). The strongest associations were for severe malaria anaemia (> 10,000 P. falciparum parasites/μl) and severe nonmalaria anaemia; the incidence rate ratios and 95% confidence intervals (CIs) for α+-thalassaemia heterozygotes and homozygotes combined compared to normal children were, for severe malaria anaemia, 0.33 (95% CI, 0.15,0.73; p = 0.006), and for severe nonmalaria anaemia, 0.26 (95% CI, 0.09,0.77; p = 0.015). Conclusions Our observations suggest, first that selection for α+-thalassaemia might be mediated by a specific effect against severe anaemia, an observation that may lead to fresh insights into the aetiology of this important condition. Second, although α+-thalassaemia is strongly protective against severe and fatal malaria, its effects are not detectable at the level of any other malaria outcome; this result provides a cautionary example for studies aimed at testing malaria interventions or identifying new malaria-protective genes.
References
[1]
Murray CJ, Lopez AD (1997) Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349: 1436–1442.
[2]
Snow RW, Craig MH, Newton CRJC, Steketee RW (2003) The public health burden of P. falciparum malaria in Africa: Deriving the numbers . Bethesda: Fogerty International Center, National Institutes of Health.
[3]
Flint J, Harding RM, Boyce AJ, Clegg JB (1998) The population genetics of the haemoglobinopathies. Baillieres Clin Haematol 11: 1–51.
[4]
Weatherall DJ, Clegg JB (2001) The thalassaemia syndromes. 4th ed. Oxford: Blackwell Science. 846 pp.
[5]
Williams TN, Mwangi TW, Wambua S, Peto TEA, Weatherall DJ, et al. (2005) Negative epistasis between the malaria-protective effects of α +-thalassemia and the sickle cell trait. Nat Genet 37: 1253–1257.
[6]
Mwangi TW, Ross AK, Snow RW, Marsh K (2005) Case definitions of clinical malaria under different transmission conditions in Kilifi District, Kenya. J Infect Dis 191: 1932–1939.
[7]
Nyakeriga AM, Troye-Blomberg M, Chemtai AK, Marsh K, Williams TN (2004) Malaria and nutritional status in children living on the coast of Kenya. Am J Clin Nutr 80: 1604–1610.
[8]
Snow RW, Howard SC, Mung'Ala-Odera V, English M, Molyneux CS, et al. (2000) Paediatric survival and re-admission risks following hospitalization on the Kenyan coast. Trop Med Int Health 5: 377–383.
[9]
Nevill CG, Some ES, Mung'ala VO, Mutemi W, New L, et al. (1996) Insecticide-treated bednets reduce mortality and severe morbidity from malaria among children on the Kenyan coast. Trop Med Int Health 1: 139–146.
[10]
Snow RW, McCabe E, Mbogo CN, Molyneux CS, Some ES, et al. (1999) The effect of delivery mechanisms on the uptake of bed net re-impregnation in Kilifi District, Kenya. Health Policy Plan 14: 18–25.
[11]
World Health Organization (1990) Severe and complicated malaria. Trans R Soc Trop Med Hyg 84: Suppl 2S1–S65.
[12]
Williams TN, Mwangi TW, Wambua S, Alexander ND, Kortok M, et al. (2005) Sickle cell trait and the risk of malaria and other childhood diseases. J Infect Dis 192: 178–186.
[13]
Chong SS, Boehm CD, Higgs DR, Cutting GR (2000) Single-tube multiplex-PCR screen for common deletional determinants of alpha-thalassemia. Blood 95: 360–362.
[14]
Williams TN, Wambua S, Uyoga S, Macharia A, Mwacharo JK, et al. (2005) Both heterozygous and homozygous alpha+ thalassemias protect against severe and fatal malaria on the coast of Kenya. Blood 106: 368–371.
[15]
Wambua S, Mwacharo J, Uyoga S, Macharia A, Williams TN (2006) Co-inheritance of α +thalassaemia and sickle trait results in specific effects on haematological parameters. Br J Haematol. In press.
[16]
Yates SNR (1995) Human genetic diversity and selection by malaria [dissertation]. Oxford. 271 p. Available from the Bodlean Library, University of Oxford, Oxford, UK.
[17]
Armitage P, Berry G, Matthews JNS, editors. (2001) Statistical methods in medical research. 4th ed. Oxford: Blackwell Scientific Publications. 817 p.
[18]
Flint J, Hill AV, Bowden DK, Oppenheimer SJ, Sill PR, et al. (1986) High frequencies of alpha-thalassaemia are the result of natural selection by malaria. Nature 321: 744–750.
[19]
Modiano G, Morpurgo G, Terrenato L, Novelletto A, Di Rienzo A, et al. (1991) Protection against malaria morbidity: Near-fixation of the alpha-thalassemia gene in a Nepalese population. Am J Hum Genet 48: 390–397.
[20]
Flint J, Harding RM, Boyce AJ, Clegg JB (1993) The population genetics of the haemoglobinopathies. Baillieres Clin Haematol 6: 215–262.
[21]
Allen SJ, O'Donnell A, Alexander ND, Alpers MP, Peto TE, et al. (1997) Alpha +thalassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci U S A 94: 14736–14741.
[22]
Mockenhaupt FP, Ehrhardt S, Gellert S, Otchwemah RN, Dietz E, et al. (2004) α +thalassemia protects African children from severe malaria. Blood 104: 2003–2006.
[23]
Roberts DJ, Williams TN (2003) Haemoglobinopathies and resistance to malaria. Redox Rep 8: 304–310.
[24]
Oppenheimer SJ, Hill AV, Gibson FD, Macfarlane SB, Moody JB, et al. (1987) The interaction of alpha thalassaemia with malaria. Trans R Soc Trop Med Hyg 81: 322–326.
[25]
Williams TN, Maitland K, Bennett S, Ganczakowski M, Peto TE, et al. (1996) High incidence of malaria in alpha-thalassaemic children. Nature 383: 522–525.
[26]
Williams TN (1999) Mechanisms of malaria protection in the thalassaemia syndromes [dissertation]. London: University of London. 269 p. Available from the Bodlean Library, University of Oxford, Oxford, UK.
[27]
Mockenhaupt FP, Falusi AG, May J, Ademowo OG, Olumese PE, et al. (1999) The contribution of alpha+-thalassaemia to anaemia in a Nigerian population exposed to intense malaria transmission. Trop Med Int Health 4: 302–307.
[28]
Maitland K, Williams TN, Peto TE, Day KP, Clegg JB, et al. (1997) Absence of malaria-specific mortality in children in an area of hyperendemic malaria. Trans R Soc Trop Med Hyg 91: 562–566.
[29]
Maitland K, Williams TN, Bennett S, Newbold CI, Peto TE, et al. (1996) The interaction between and in children on Espiritu Santo island, Vanuatu. Trans R Soc Trop Med Hyg 90: 614–620.
[30]
Maitland K, Williams TN, Newbold CI (1997) and : Biological interactions and the possibility of cross-species immunity. Parasitol Today 13: 227–231.
[31]
Maitland K, Bunce M, Harding RM, Barnardo MC, Clegg JB, et al. (2004) HLA class-I and class-II allele frequencies and two-locus haplotypes in Melanesians of Vanuatu and New Caledonia. Tissue Antigens 64: 678–686.
[32]
Maitland K, Kyes S, Williams TN, Newbold CI (2000) Genetic restriction of in an area of stable transmission: An example of island evolution? Parasitology 120: 335–343.
[33]
Williamson WA, Greenwood BM (1978) Impairment of the immune response to vaccination after acute malaria. Lancet 1: 1328–1329.
[34]
Kwiatkowski D, Bate CA, Scragg IG, Beattie P, Udalova I, et al. (1997) The malarial fever response—Pathogenesis, polymorpism and prospects for intervention. Ann Trop Med Parasitol 91: 533–542.
[35]
Williams TN, Maitland K, Ganczakowski M, Peto TE, Clegg JB, et al. (1996) Red blood cell phenotypes in the alpha + thalassaemias from early childhood to maturity. Br J Haematol 95: 266–272.
[36]
Ganczakowski M, Bowden DK, Maitland K, Williams TN, O'Shaughnessy D, et al. (1995) Thalassaemia in Vanuatu, south-west Pacific: Frequency and haematological phenotypes of young children. Br J Haematol 89: 485–495.
[37]
Beutler E, West C (2005) Hematologic differences between African-Americans and whites: The roles of iron deficiency and alpha-thalassemia on hemoglobin levels and mean corpuscular volume. Blood 106: 740–745.
[38]
Menendez C, Fleming AF, Alonso PL (2000) Malaria-related anaemia. Parasitol Today 16: 469–476.
[39]
Menendez C, Kahigwa E, Hirt R, Vounatsou P, Aponte JJ, et al. (1997) Randomised placebo-controlled trial of iron supplementation and malaria chemoprophylaxis for prevention of severe anaemia and malaria in Tanzanian infants. Lancet 350: 844–850.
[40]
Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, et al. (1995) Indicators of life-threatening malaria in African children. N Engl J Med 332: 1399–1404.
[41]
Dicko A, Klion AD, Thera MA, Sagara I, Yalcouye D, et al. (2004) The etiology of severe anemia in a village and a periurban area in Mali. Blood 104: 1198–1200.
[42]
Mockenhaupt FP, Bienzle U, May J, Falusi AG, Ademowo OG, et al. (1999) infection: Influence on hemoglobin levels in alpha-thalassemia and microcytosis. J Infect Dis 180: 925–928.
[43]
Mockenhaupt FP, May J, Bergqvist Y, Meyer CG, Falusi AG, et al. (2001) Evidence for a reduced effect of chloroquine against in alpha-thalassaemic children. Trop Med Int Health 6: 102–107.
[44]
Nyakeriga AM, Troye-Blomberg M, Mwacharo JK, Wambua S, Williams TN (2005) Nutritional iron status in children with alpha+ thalassemia and the sickle cell trait in a malaria endemic area on the coast of Kenya. Haematologica 90: 552–554.
[45]
Weatherall DJ, Abdalla S (1982) The anaemia of malaria. Br Med Bull 38: 147–151.
[46]
Cockburn IA, Mackinnon MJ, O'Donnell A, Allen SJ, Moulds JM, et al. (2004) A human complement receptor 1 polymorphism that reduces rosetting confers protection against severe malaria. Proc Natl Acad Sci U S A 101: 272–277.
[47]
Carlson J, Helmby H, Hill AV, Brewster D, Greenwood BM, et al. (1990) Human cerebral malaria: Association with erythrocyte rosetting and lack of anti-rosetting antibodies. Lancet 336: 1457–1460.
[48]
Treutiger CJ, Hedlund I, Helmby H, Carlson J, Jepson A, et al. (1992) Rosette formation in isolates and anti-rosette activity of sera from Gambians with cerebral or uncomplicated malaria. Am J Trop Med Hyg 46: 503–510.
[49]
Rowe A, Obeiro J, Newbold CI, Marsh K (1995) rosetting is associated with malaria severity in Kenya. Infect Immun 63: 2323–2326.
[50]
Ringwald P, Peyron F, Lepers JP, Rabarison P, Rakotomalala C, et al. (1993) Parasite virulence factors during falciparum malaria: Rosetting, cytoadherence, and modulation of cytoadherence by cytokines. Infect Immun 61: 5198–5204.
[51]
Carlson J, Nash GB, Gabutti V, al-Yaman F, Wahlgren M (1994) Natural protection against severe malaria due to impaired rosette formation. Blood 84: 3909–3914.
[52]
Udomsangpetch R, Sueblinvong T, Pattanapanyasat K, Dharmkrong-at A, Kittikalayawong A, et al. (1993) Alteration in cytoadherence and rosetting of -infected thalassemic red blood cells. Blood 82: 3752–3759.
[53]
Luzzi GA, Merry AH, Newbold CI, Marsh K, Pasvol G, et al. (1991) Surface antigen expression on -infected erythrocytes is modified in alpha- and beta-thalassemia. J Exp Med 173: 785–791.
[54]
Williams TN, Weatherall DJ, Newbold CI (2002) The membrane characteristics of -infected and -uninfected heterozygous alpha(0)thalassaemic erythrocytes. Br J Haematol 118: 663–670.
